Divi’s Laboratories reported a robust financial performance for the second quarter of FY26, with consolidated net profit soaring by 35% year-on-year to Rs 689 crore. The pharmaceutical major also witnessed a significant 16% increase in consolidated revenue from operations, reaching Rs 2,715 crore for the period.